The nutraceuticals industry is going to the dogs. And the cats, and the horses, and the cows…
After all, if it has four legs, you can bet it has a two-legged companion who wants it to be healthy, beautiful, economical, or profitable. Whether the motivation is commerce or compassion, nutraceutical products are newly but firmly entrenched in the global animal village, and consumers across the world are spending.
Even as the world’s nutraceutical markets are working towards a new era of regulations, these regulations, in many jurisdictions, do not apply to nutraceuticals for animal use. Thus, companies marketing veterinary nutraceuticals are often led into a vague and un-navigable regulatory territory. And species-specific data on toxicity and efficacy are often unavailable, leaving companies facing a substantial research and development investment that is frequently unachievable.
Some questions that often need to be answered by companies marketing veterinary nutraceuticals:
- Are toxicity / efficacy data on our veterinary nutraceutical already available, or do we need to generate our own?
- Is there research funding available to help with the substantial cost of launching a new veterinary nutraceutical?
- What are the tissue retention characteristics of our nutraceutical in livestock?
- Is there potential for human toxicity after exposure to meat from nutraceutical-fed livestock?
- Are there species-specific responses to our veterinary nutraceutical?
- Will my nutraceutical product be restricted for use in performance animals?
- What steps are required to register a veterinary nutraceutical in the marketplace?
CANTOX HEALTH SCIENCES INTERNATIONAL introduces a new division which specializes in natural animal supplements. We save our clients valuable time and money with our unique expertise in the area of natural animal supplements, including research and development program planning and management; design, implementation and critical evaluation of efficacy studies, toxicity and pharmacokinetics; risk assessment of individual constituents, including secondary risk to humans eating foods obtained from livestock exposed to nutraceutical treatment; and facilitating client access to external research funding.